HIV-1 p24 derived epitopes modulate KIR2DL2-binding to HLA-Cw03

D Van Baarle,L Fadda,Nh Van Teijlingen,C Körner,Mn Carrington,M Altfeld,C Brander

doi:10.1186/1742-4690-9-s2-p180

Abstract

Background Recent studies have suggested that HIV-1 can evade Natural Killer (NK)-cell-mediated immunity by mutating viral epitopes to enhance engagement of inhibitory Killer Ig-like receptors (KIRs) expressed on NK cells. However, the precise mechanisms modulating the interaction of inhibitory KIRs and their HLA class I ligands, and the role that HIV-1 epitopes might play in this interaction are not well understood. In this study we investigated whether HLA-Cw3-presented epitopes within HIV-1 p24 Gag can modulate binding of KIR2DL2, an inhibitory KIR, to HLA-Cw03. Methods Using tapasin-deficient 721.220 cell line expressing HLA-Cw*0304 we initially screened for HIV-1 peptides that stabilized HLA-Cw*0304 expression using 222 10mer peptides overlapping by 9 amino acids spanning the entire HIV-1 p24 Gag sequence. Peptides stabalizing HLA-Cw*0304 expression were thereafter investigated for their ability to facilitate binding of a KIR2DL2-IgG fusion construct.

Highlights

Recent studies have suggested that HIV-1 can evade Natural Killer (NK)-cell-mediated immunity by mutating viral epitopes to enhance engagement of inhibitory Killer Ig-like receptors (KIRs) expressed on NK cells
The precise mechanisms modulating the interaction of inhibitory KIRs and their HLA class I ligands, and the role that HIV-1 epitopes might play in this interaction are not well understood
In this study we investigated whether HLA-Cw3-presented epitopes within HIV-1 p24 Gag can modulate binding of KIR2DL2, an inhibitory KIR, to HLA-Cw03

Summary

Background

Recent studies have suggested that HIV-1 can evade Natural Killer (NK)-cell-mediated immunity by mutating viral epitopes to enhance engagement of inhibitory Killer Ig-like receptors (KIRs) expressed on NK cells. In this study we investigated whether HLA-Cw3-presented epitopes within HIV-1 p24 Gag can modulate binding of KIR2DL2, an inhibitory KIR, to HLA-Cw03. NK cell receptor KIR2DL2 to its ligand HLA-Cw3, and are in line with recent data suggesting that the sequence of the HLA class I presented epitope has an important impact on the interaction between KIR and HLA class I (Boyington et al Nature 2000, Vivian et al Nature 2011).

Methods

Results

Conclusion